LUIS ALENCAR BIURRUM BORBA
Professor Adjunto de Neurocirurgia da Universidade Federal do Paraná . Chefe do Serviço de Neurocirurgia do Hospital de Clinicas da UFPR. Professor Honorário da Universidade SECHENOV, Moscou, Rússia Mestre em Neurocirurgia pela UNIFESP. Pós-Graduado em Cirurgia da Base do Crânio pela Universidade do Arkansas - EUA. Doutor em Clinica Cirurgica pela Universidade de São Paulo - USP-RP. Coordenador do Serviço de Neurocirurgia do Hospital Universitário Evangélico de Curitiba,
Check the activity agenda
Friday, March 22, 2024
Room 2
13:30-15:30
SESSION 2: SKULL BASE TUMORS
How to avoid complications in skull base surgery?
Open approaches for Clival Chordomas: benefits, boundaries, and considerations
Endoscopic approaches for Clival Chordomas: benefits, boundaries, and considerations
Chordomas: exploring the landscape of clinical treatment options
What is the optimal radiation therapy planning for skull base chordomas?
Radiotherapy for recurrent/unresectable functioning pituitary adenomas - endocrinological results and tumor control
Is there any role of NGS and methylation profile for skull base tumors?
Discussion
Moderator: Antonio Aversa Dutra Do Souto (RJ)
Moderator: Bernardo Peres Salvajoli (SP)
Moderator: Mauro Takao Suzuki (DF)
Moderator: Cleiton Formentin (SP)
How to avoid complications in skull base surgery?
Speaker: Gustavo Simiano Jung (PR)
Open approaches for Clival Chordomas: benefits, boundaries, and considerations
Speaker: Luis Alencar Biurrum Borba (PR)
Endoscopic approaches for Clival Chordomas: benefits, boundaries, and considerations
Speaker: João Paulo Almeida (Estados Unidos)
Chordomas: exploring the landscape of clinical treatment options
Speaker: Rodrigo Ramella Munhoz (SP)
What is the optimal radiation therapy planning for skull base chordomas?
Speaker: Samir Abdallah Hanna (SP)
Radiotherapy for recurrent/unresectable functioning pituitary adenomas - endocrinological results and tumor control
Speaker: Eduardo Weltman (SP)
Is there any role of NGS and methylation profile for skull base tumors?
Speaker: Martha Quezado (Estados Unidos)
Discussion